𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O01 Autologous cell therapy in oculopharyngeal muscular dystrophy (OPMD)

✍ Scribed by Périé, S.; Trollet, C.; Mouly, V.; Larghero, J.; Mamchaoui, K.; Bouazza, B.; Toy-Miou, M.; Marolleau, J.P.; Eymard, B.; Laforêt, P.; Chapon, F.; Butler-Browne, G.; Guily, J. Lacau St

Book ID
123119232
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
88 KB
Volume
24
Category
Article
ISSN
0960-8966

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oculopharyngeal muscular dystrophy (OPMD
Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene
✍ Barbara M. van der Sluijs; Baziel G.M. van Engelen; Lies H. Hoefsloot 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

Oculopharyngeal muscular dystrophy (OPMD) is a late onset autosomal dominant muscle disorder. The OPMD-locus has been mapped to chromosome 14q11.2-q13. The polyadenylate binding protein nuclear 1 (PABPN1; PABP2) gene has been identified as the mutated gene. The mutation consists of a short meiotical

Challenges: Cell transplantation and gen
Challenges: Cell transplantation and gene therapy in muscular dystrophy
✍ Jennifer E. Morgan; Terence A. Partridge 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

## Abstract Duchenne's muscular dystrophy (DMD), which affects 1/3500 live male births, involves a progressive degeneration of skeletal and cardiac muscle, leading to early death. The protein dystrophin is lacking in DMD and present, but defective, in the allelic, less severe, Becker muscular dystr